Market Place
Sourcing Support
Novartis loses latest bid to block generic version of blockbuster heart drug
17 Oct 2024 //
REUTERS
USV launches heart failure medication at 8rs per 50mg tablet
15 Oct 2024 //
EXPRESSPHARMA
Macleods`s Generics Amlodipine, Valsartan Receives Approval in US
11 Oct 2024 //
FDA
Novartis loses initial bid to block generic of best-selling heart drug
13 Aug 2024 //
REUTERS
Zenara`s Generics Valsartan Receives Approval in US
05 Aug 2024 //
FDA
EDQM issued CEP Certificate for “Valsartan”
12 Jul 2024 //
PRESS RELEASE
Zydus Life hits 52-week high on USFDA nod for Sacubitril and Valsartan
11 Jul 2024 //
ECONOMIC TIMES
Zydus Pharms Generic Sacubitril :Valsartan Receives Approval in US
09 Jul 2024 //
FDA
Novartis heart drug price may fall by 60% on generic rollouts
19 Jan 2023 //
ECONOMIC TIMES
Dr Reddy`s cuts price of cardiovascular drug Cidmus
19 Jan 2023 //
ECONOMIC TIMES
HC reserves order on Natco`s plea over patent for Novartis drug
11 Jan 2023 //
ECONOMIC TIMES
Novartis pays $245M to settle Exforge generic pay-for-delay suit
04 Jan 2023 //
FIERCE PHARMA
Top Novartis cardiac drug to go off patent
03 Dec 2022 //
ECONOMICTIMES
IOL Chemicals secures patent for invention related to preparation of Sartan drugs
27 Nov 2022 //
BUSINESS-STANDARD
Prompted by recent recalls, regulators scramble to address novel nitrosamines
31 Oct 2022 //
RAPS
Prinston`s Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.
19 Sep 2022 //
FDA
Novartis files FDA appeal in bid to block Entresto generics
17 Sep 2022 //
FIERCEPHARMA
Dr. Reddy`s Announces the Launch of Valsartan Tablets, USP in the U.S. Market
09 Dec 2021 //
BUSINESSWIRE
Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
19 Nov 2021 //
FIERCEPHARMA
Novitium Pharma`s Generic Valsartan Receives Approvals in US
03 Nov 2021 //
FDA
Delhi HC restrains generic firms from making, selling patent drug of Novartis
03 Nov 2021 //
ECONOMICTIMES
ScieGen Pharma`s Generic ValsartanReceives Approval In US
30 Oct 2021 //
FDA
ScieGen Pharma`s Generic ValsartanReceives Approval In US
30 Oct 2021 //
FDA
Dr. Reddy`s Generics Valsartan Receives Approval in US
07 Oct 2021 //
FDA
Multiple lots of irbesartan, losartan and valsartan drugs recalled
17 Sep 2021 //
NEWSWIRE
Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs
15 Jun 2021 //
HEALTH CANADA
Novartis Entresto® indicated for treatment of hypertension in China
10 Jun 2021 //
PRESS RELEASE
Health Canada Issues Recall of Sandoz Canada`s Valsartan
27 May 2021 //
HEALTH CANADA
Sacubitril/valsartan not superior to valsartan alone in advanced HFrEF: LIFE
17 May 2021 //
HEALIO
Novartis whiffs on Entresto study after heart attacks that doesn`t going down
17 May 2021 //
ENDPTS
Novartis` Entresto came up short in a post-heart attack phase 3
27 Apr 2021 //
FIERCEPHARMA
FDA reviewers argue for Novartis ahead of Entresto advisory panel confab
14 Dec 2020 //
FIERCEPHARMA
It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement.
02 Jul 2020 //
NYTIMES
AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates
10 May 2020 //
MEDICAL
Cosentyx, Entresto drive topline growth for Novartis in Q4
30 Jan 2020 //
PMLIVE
Industry faces new risks from old drugs, more testing in 2020
19 Dec 2019 //
FIERCE PHARMA
Sun Pharma gets partial relief from US court in litigation on generic drugs
03 Dec 2019 //
BUSINESS-STANDARD
Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF
18 Nov 2019 //
PR NEWSWIRE
6 Major Drug Recalls from the Past
17 Oct 2019 //
BIOSPACE
FDA tags Torrent as key offender in production of tainted blood pressure meds
17 Oct 2019 //
FIERCE PHARMA
Mylan to invest $1 billion in India on capex in 6 years
29 Sep 2019 //
THE ECONOMIC TIMES
FDA finds impurity in popular heartburn medicine Zantac that could cause cancer
14 Sep 2019 //
CNBC
US officials worried about Chinese control of American drug supply
13 Sep 2019 //
NBCNEWS
EMA, FDA Begin Reviewing Heartburn Medicines for Carcinogen
13 Sep 2019 //
RAPS
Aurobindo recalls mislabeled statin tablets from the U.S. market
10 Sep 2019 //
FIERCE PHARMA
Square Pharma`s Generic Valsartan Receives Approval in US
05 Sep 2019 //
FDA
FDA says widening probe on generic drug impurities
29 Aug 2019 //
REUTERS
The sartan saga: Recapping the recalls
15 Aug 2019 //
IN-PHARMATECHNOLOGY
NDEA & NDMA Impurities: Another Indian Manuf. Receives an FDA Warning Letter
13 Aug 2019 //
RAPS
Novartis` Entresto falls short at Ph 3 in heart failure with preserved ejection
25 Jul 2019 //
PHARMAFILE
US FDA finds "significant violations" at India`s Strides plant
16 Jul 2019 //
ECONOMIC TIMES
Manufacturing Concerns Lead FDA to Pull 31 Apotex ANDAs
09 Jul 2019 //
RAPS
FDA Sends Warning Letters to Aurobindo, API Repackers
03 Jul 2019 //
RAPS
Aurobindo gets warning letter over valsartan recall mess
03 Jul 2019 //
FIERCE PHARMA
Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS
02 Jul 2019 //
FIERCE PHARMA
Pharmacy takes FDA to task in citizen petition over tainted valsartan
20 Jun 2019 //
FIERCE PHARMA
Fourth Carcinogen Discovered in Heart Pills Used by Millions
19 Jun 2019 //
BLOOMBERG
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply
14 Jun 2019 //
FIERCE PHARMA
